CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL

DRUG2 trials

Sponsors

Ranbaxy Laboratories Limited

Conditions

Healthy

Unknown Phase

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions

CompletedNCT00778557

Ranbaxy Laboratories LimitedHealthy

Start: 2005-06-30End: 2005-07-31Updated: 2008-10-23

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions

CompletedNCT00778739

Ranbaxy Laboratories LimitedHealthy

Start: 2005-06-30End: 2005-07-31Updated: 2008-10-23